Abstract:Arginase, often perceived solely as the last of the now six enzymes of the urea cycle, exists in two forms and has a broad tissue distribution. A cytosolic form, AI, is highly expressed in the liver and is thought to be primarily involved in ureagenesis. A mitochondrial form, AII, has been thought to be more widely expressed and to be involved in the biosynthesis of polyamines, the amino acids ornithine, proline, and glutamate and in the inflammatory process, among others. This paper will address recent experiments that cast some doubt on the validity of these distinctions. Studies have now suggested that macrophages may express AI or AII in different experimental conditions, both in vivo and in vitro. In contrast, most studies, at least in cell culture, suggest that AII may be most highly expressed in cancers of a number of different types. Inhibition of arginase activity in vivo and in vitro has implicated this activity in maintaining ornithine levels for polyamine synthesis. In situ and "quantitative" PCR studies in mouse have demonstrated that AI and not AII is the predominant isoform expressed during development and in the majority of organs. Mouse knockout models for both AI and AII have been produced and are available to address their functions. Surprisingly, the AII knockout animal has no apparent phenotype except for some diminished fertility in homozygous males, consistent with the belief that AII, highly expressed in prostate, is important for sperm function in semen. The AI knockout animal has a more dramatic phenotype and dies at 10-12 days of life of hyperammonemia. The reason for the prolonged survival, as compared to other urea cycle knockout animals, may be due to the later occurrence of hypo-ornithinemia, a contention not yet proven. Transgenic manipulation of the AI knockout animal and breeding the AI and AII knockouts into single animals may address the ability of AII to rescue animals from some of the metabolic consequences of AI deficiency, as appears to happen in man. Newborn screening has given particular hope to patients affected by arginase (AI) deficiency. Increased arginine appears to be detectable by newborn screening with tandem mass spectrometry and the past years continue to demonstrate the therapeutic effectiveness of dietary management of the disorder, with patients treated from birth remaining normal and those treated late, ceasing to deteriorate and even improving in cognitive and physical functioning. Finally, prenatal diagnosis appears to be possible as was predicted, but never proven, some years ago.

Activities of arginase I and II are limiting for endothelial cell proliferation.

Arginases I and II: do their functions overlap?

[Inhibitory effects of emodin on proliferation of rat vascular smooth muscle cell induced by angiotensin II].

Effects of Astragalus on Number and Activity of Peripheral Endothelial Progenitor Cells

L-Arginine Stimulates Cat-1-Mediated Arginine Uptake and Regulation of Inducible Nitric Oxide Synthase for the Growth of Chick Intestinal Epithelial Cells

L-arginine Upregulates the Gene Expression of Target of Rapamycin Signaling Pathway and Stimulates Protein Synthesis in Chicken Intestinal Epithelial Cells

Arginine and its metabolites stimulate proliferation, differentiation, and physiological function of porcine trophoblast cells through β-catenin and mTOR pathways

(210) Expression Of Potential Functional Significance Of Arginase Isoenzymes (L-Arginine-Aminidohydrolases) In The Human Prostate

Dietary L-arginine Levels Affect the Liver Protein Turnover and Alter the Expression of Genes Related to Protein Synthesis and Proteolysis of Laying Hens.

Polyaspartoyl.L-Arginine Enhances Prostacyclin Synthesis In Rat Aortic Endothelial Cells

Effects of Dietary L-arginine Levels on Small Intestine Protein Turnover and the Expression of Genes Related to Protein Synthesis and Proteolysis of Layers

Effects of puerarin on proliferation of bovine artery endothelial cells

Human Recombinant Arginase Enzyme Reduces Plasma Arginine in Mouse Models of Arginase Deficiency

Downregulation of eNOS and preserved endothelial function in endothelial-specific arginase 1-deficient mice

Effects of IGF-II on promoting proliferation and regulating nitric oxide synthase gene expression in mouse osteoblast-like cell

Inhibition of heat shock protein 90 (hsp90) in proliferating endothelial cells uncouples endothelial nitric oxide synthase activity.

Urea cycle metabolism: effects of supplemental ornithine or citrulline on performance, tissue amino acid concentrations and enzymatic activity in young pigs fed arginine-deficient diets.

Regulation of Protein Expression by L-arginine in Endothelial Cells

Dichotomous effects of isomeric secondary amines containing an aromatic nitrile and nitro group on human aortic smooth muscle cells via inhibition of cystathionine-γ-lyase

Functional Roles of Arginine During the Peri-Implantation Period of Pregnancy. III. Arginine Stimulates Proliferation and Interferon Tau Production by Ovine Trophectoderm Cells via Nitric Oxide and Polyamine-TSC2-MTOR Signaling Pathways1

Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca2+-dependent eNOS activation